The global venous leg ulcers treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of venous leg ulcers and rising awareness about the disease. The market is also driven by factors such as increasing number of patients with chronic diseases, which are associated with venous leg ulcers.
The global venous leg ulcers treatment market can be segmented on the basis of type, application and region. On the basis of type, it can be segmented into curexcell, CVB141B, granexin and H802247; on the basis of application it can be segmented into hospital use and clinic use; on the basis of region it can be segmented into North America (US, Canada), Latin America (Brazil), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Increasing prevalence of venous leg ulcers is one of the major factors driving the growth of this market.
- Rising geriatric population and increasing incidence rates are also some other factors that are driving the growth of this market globally.
- Increasing awareness about venous leg ulcers treatment and rising demand for minimally invasive procedures are some other factors that are contributing to the growth of this market globally in recent years .
Industry Growth Insights published a new data on “Venous Leg Ulcers Treatment Market”. The research report is titled “Venous Leg Ulcers Treatment Market research by Types (CureXcell, CVBT-141B, Granexin, HP-802247, Others), By Applications (Hospital, Clinic, Home Use), By Players/Companies CardioVascular BioTherapeutics Inc, CytoTools AG, Daval International Ltd, Factor Therapeutics Ltd, FirstString Research Inc, GangaGen Inc, Hypo-Stream Ltd, Leap Therapeutics Inc, MediWound Ltd, NovaLead Pharma Pvt Ltd, Promore Pharma, RegeneRx Biopharmaceuticals Inc, RMB-Research GmbH, Stratatech Corp”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Venous Leg Ulcers Treatment Market Research Report
By Type
CureXcell, CVBT-141B, Granexin, HP-802247, Others
By Application
Hospital, Clinic, Home Use
By Companies
CardioVascular BioTherapeutics Inc, CytoTools AG, Daval International Ltd, Factor Therapeutics Ltd, FirstString Research Inc, GangaGen Inc, Hypo-Stream Ltd, Leap Therapeutics Inc, MediWound Ltd, NovaLead Pharma Pvt Ltd, Promore Pharma, RegeneRx Biopharmaceuticals Inc, RMB-Research GmbH, Stratatech Corp
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Venous Leg Ulcers Treatment Market Report Segments:
The global Venous Leg Ulcers Treatment market is segmented on the basis of:
Types
CureXcell, CVBT-141B, Granexin, HP-802247, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Home Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- CardioVascular BioTherapeutics Inc
- CytoTools AG
- Daval International Ltd
- Factor Therapeutics Ltd
- FirstString Research Inc
- GangaGen Inc
- Hypo-Stream Ltd
- Leap Therapeutics Inc
- MediWound Ltd
- NovaLead Pharma Pvt Ltd
- Promore Pharma
- RegeneRx Biopharmaceuticals Inc
- RMB-Research GmbH
- Stratatech Corp
Highlights of The Venous Leg Ulcers Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CureXcell
- CVBT-141B
- Granexin
- HP-802247
- Others
- By Application:
- Hospital
- Clinic
- Home Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Venous Leg Ulcers Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Venous leg ulcers (VLUs) are a type of skin lesion that can occur on the legs. They are caused by damage to the veins in the lower leg, and they can be very painful. VLUs often require treatment with antibiotics and painkillers to relieve symptoms. In some cases, surgery may also be necessary to remove the lesion.
Some of the key players operating in the venous leg ulcers treatment market are CardioVascular BioTherapeutics Inc, CytoTools AG, Daval International Ltd, Factor Therapeutics Ltd, FirstString Research Inc, GangaGen Inc, Hypo-Stream Ltd, Leap Therapeutics Inc, MediWound Ltd, NovaLead Pharma Pvt Ltd, Promore Pharma, RegeneRx Biopharmaceuticals Inc, RMB-Research GmbH, Stratatech Corp.
The venous leg ulcers treatment market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Venous Leg Ulcers Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Venous Leg Ulcers Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Venous Leg Ulcers Treatment Market - Supply Chain
4.5. Global Venous Leg Ulcers Treatment Market Forecast
4.5.1. Venous Leg Ulcers Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Venous Leg Ulcers Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Venous Leg Ulcers Treatment Market Absolute $ Opportunity
5. Global Venous Leg Ulcers Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
5.3.1. CureXcell
5.3.2. CVBT-141B
5.3.3. Granexin
5.3.4. HP-802247
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Venous Leg Ulcers Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Home Use
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Venous Leg Ulcers Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Venous Leg Ulcers Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Venous Leg Ulcers Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Venous Leg Ulcers Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Venous Leg Ulcers Treatment Demand Share Forecast, 2019-2026
9. North America Venous Leg Ulcers Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Home Use
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
9.7.1. CureXcell
9.7.2. CVBT-141B
9.7.3. Granexin
9.7.4. HP-802247
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Venous Leg Ulcers Treatment Demand Share Forecast, 2019-2026
10. Latin America Venous Leg Ulcers Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Home Use
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
10.7.1. CureXcell
10.7.2. CVBT-141B
10.7.3. Granexin
10.7.4. HP-802247
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Venous Leg Ulcers Treatment Demand Share Forecast, 2019-2026
11. Europe Venous Leg Ulcers Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Venous Leg Ulcers Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Home Use
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
11.7.1. CureXcell
11.7.2. CVBT-141B
11.7.3. Granexin
11.7.4. HP-802247
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o- Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Venous Leg Ulcers Treatment Demand Share, 2019-2026
12. Asia Pacific Venous Leg Ulcers Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Venous Leg Ulcers Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Home Use
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
12.7.1. CureXcell
12.7.2. CVBT-141B
12.7.3. Granexin
12.7.4. HP-802247
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Venous Leg Ulcers Treatment Demand Share, 2019-2026
13. Middle East & Africa Venous Leg Ulcers Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Venous Leg Ulcers Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Venous Leg Ulcers Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Home Use
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Venous Leg Ulcers Treatment Market Size and Volume Forecast by Type
13.7.1. CureXcell
13.7.2. CVBT-141B
13.7.3. Granexin
13.7.4. HP-802247
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Venous Leg Ulcers Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Venous Leg Ulcers Treatment Market: Market Share Analysis
14.2. Venous Leg Ulcers Treatment Distributors and Customers
14.3. Venous Leg Ulcers Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. CardioVascular BioTherapeutics Inc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CytoTools AG
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Daval International Ltd
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Factor Therapeutics Ltd
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. FirstString Research Inc
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GangaGen Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hypo-Stream Ltd
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Leap Therapeutics Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. MediWound Ltd
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. NovaLead Pharma Pvt Ltd
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Promore Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. RegeneRx Biopharmaceuticals Inc
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. RMB-Research GmbH
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Stratatech Corp
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
